| Publication |
Sentence |
Publish Date |
Extraction Date |
Species |
| Zexiang Ouyang, Li Ch. A case of recurrent neuroleptic malignant syndrome. Shanghai archives of psychiatry. vol 25. issue 4. 2014-07-03. PMID:24991164. |
neuroleptic malignant syndrome (nms) is a life-threatening neurologic complication associated with the use of neuroleptic agents and characterized by a distinctive clinical syndrome of fever, rigidity, autonomic nervous system dysfunction and mental status change. |
2014-07-03 |
2023-08-13 |
Not clear |
| Jing Chen, Shengli Zh. A case of neuroleptic malignant syndrome induced by perospirone. Shanghai archives of psychiatry. vol 25. issue 6. 2014-07-03. PMID:24991182. |
neuroleptic malignant syndrome (nms) is a rare but life-threatening condition induced by neuroleptic medications. |
2014-07-03 |
2023-08-13 |
Not clear |
| Sylvain Grignon, Jean Ianic Brethes, Martine Chamberland, Daniel B Guimarae. Incipient neuroleptic malignant syndrome with quetiapine/paroxetine combination treatment: atypical presentation and early, successful rechallenge with olanzapine. International journal of psychiatry in clinical practice. vol 9. issue 4. 2014-06-17. PMID:24930930. |
a 26-year-old caucasian male developed incipient neuroleptic malignant syndrome (nms) during the course of paranoid schizophrenia with catatonic signs at admission, while on quetiapine/paroxetine combination treatment. |
2014-06-17 |
2023-08-13 |
Not clear |
| Ilya Reznik, Baruch Spivak, Rima Melman, Moshe Kotler, Abraham Weizman, Roberto Meste. Safety and efficacy of long-term low-dose clozapine aftercare treatment in a patient with learning difficulties who suffered from neuroleptic malignant syndrome. International journal of psychiatry in clinical practice. vol 6. issue 2. 2014-06-17. PMID:24931940. |
neuroleptic malignant syndrome (nms) is one of the most serious complications of neuroleptic treatment and the optimal therapeutic aftercare regimen for patients is unclear. |
2014-06-17 |
2023-08-13 |
Not clear |
| Mark B Detweiler, Kelly Sullivan, Taral R Sharma, Kye Y Kim, Jonna G Detweile. Case reports of neuroleptic malignant syndrome in context of quetiapine use. The Psychiatric quarterly. vol 84. issue 4. 2014-06-09. PMID:23686527. |
a retrospective analysis was followed on 20 case reports covering the possible correlation between the atypical antipsychotic, quetiapine, and neuroleptic malignant syndrome (nms), determined by the study of 7 different nms criteria guidelines. |
2014-06-09 |
2023-08-12 |
Not clear |
| Myung Jun Lee, Chul Hyoung Lyoo, Myung Sik Le. Neuroleptic malignant syndrome in a patient with corticobasal degeneration. Journal of movement disorders. vol 4. issue 2. 2014-05-28. PMID:24868399. |
parkinson's disease is a principal underlying disease of neuroleptic malignant syndrome (nms) occurring in parkinsonian disorders, but nms may occur in patients with progressive supranuclear palsy and multiple system atrophy. |
2014-05-28 |
2023-08-13 |
Not clear |
| Deepak Hanumanthaiah, Kumar Ramanatha. Olanzepine-induced neuroleptic malignant syndrome in a case of multiple sclerosis. Indian journal of critical care medicine : peer-reviewed, official publication of Indian Society of Critical Care Medicine. vol 18. issue 3. 2014-04-04. PMID:24701071. |
suspicion of neuroleptic malignant syndrome (nms) is a frequent cause of emergent psychiatric consultation. |
2014-04-04 |
2023-08-13 |
Not clear |
| Deepali Dixit, Pranabh Shrestha, Marc Adelma. Neuroleptic malignant syndrome associated with haloperidol use in critical care setting: should haloperidol still be considered the drug of choice for the management of delirium in the critical care setting? BMJ case reports. vol 2013. 2014-03-10. PMID:23853022. |
neuroleptic malignant syndrome (nms) associated with haloperidol was suspected. |
2014-03-10 |
2023-08-12 |
Not clear |
| Koichi Nisijima, Katutoshi Shiod. A rare case of neuroleptic malignant syndrome without elevated serum creatine kinase. Neuropsychiatric disease and treatment. vol 10. 2014-03-04. PMID:24591835. |
neuroleptic malignant syndrome (nms) is a life-threatening adverse reaction to antipsychotic drugs. |
2014-03-04 |
2023-08-12 |
Not clear |
| Mayuko Uehara, Masami Inaoka, Yasuko Miyaki, Shinji Nakashima, Akira Fuzii, Tetsuya Higam. [Neuroleptic malignant syndrome after cardiac surgery]. Kyobu geka. The Japanese journal of thoracic surgery. vol 66. issue 12. 2014-02-18. PMID:24322311. |
although these drugs were not typical antipsychotics' causing neuroleptic malignant syndrome (nms), nms was strongly suspected because of his clinical appearance. |
2014-02-18 |
2023-08-12 |
Not clear |
| Rafat M Al Owesie, Asirvatham Alwin Rober. Delirium followed by neuroleptic malignant syndrome in rehabilitation setting. Is it anger reaction before discharge? The Pan African medical journal. vol 15. 2014-02-10. PMID:24009802. |
delirium and neuroleptic malignant syndrome (nms) are two uncommon syndromes that are often unrecognized or misdiagnosed by the primary physicians as functional psychiatric disorders. |
2014-02-10 |
2023-08-12 |
Not clear |
| Anna Szota, Ewa Ogłodek, Aleksander Araszkiewic. Fever development in neuroleptic malignant syndrome during treatment with olanzapine and clozapine. Pharmacological reports : PR. vol 65. issue 2. 2014-02-07. PMID:23744413. |
neuroleptic malignant syndrome (nms) is the most dangerous life-threatening complication of antipsychotic medication. |
2014-02-07 |
2023-08-12 |
Not clear |
| Eiichirou Urasaki, Takayasu Fukudome, Makoto Hirose, Shunya Nakane, Hidenori Matsuo, Yuzo Yamakaw. Neuroleptic malignant syndrome (parkinsonism-hyperpyrexia syndrome) after deep brain stimulation of the subthalamic nucleus. Journal of clinical neuroscience : official journal of the Neurosurgical Society of Australasia. vol 20. issue 5. 2014-01-30. PMID:23465352. |
neuroleptic malignant syndrome (nms), also called parkinsonism-hyperpyrexia syndrome (phs), is a severe, general, sometimes fatal, physical reaction, induced by sudden and strong blockade of dopamine receptors. |
2014-01-30 |
2023-08-12 |
Not clear |
| Young Kyoung Sa, Hyeon Yang, Hee Kyoung Jung, Jang Won Son, Seong Su Lee, Seong Rae Kim, Bong Yeon Cha, Ho Young Son, Chi-Un Pae, Soon Jib Yo. Olanzapine-induced diabetic ketoacidosis and neuroleptic malignant syndrome with rhabdomyolysis: a case report. Endocrinology and metabolism (Seoul, Korea). vol 28. issue 1. 2014-01-07. PMID:24396655. |
atypical antipsychotics have replaced conventional antipsychotics in the treatment of schizophrenia because they have less of a propensity to cause undesirable neurologic adverse events including extrapyramidal symptoms, tardive dyskinesia, and neuroleptic malignant syndrome (nms). |
2014-01-07 |
2023-08-12 |
Not clear |
| Faruk Uguz, Erdem Önder Sonme. Neuroleptic malignant syndrome following combination of sertraline and paroxetine: a case report. General hospital psychiatry. vol 35. issue 3. 2013-12-26. PMID:23312145. |
neuroleptic malignant syndrome (nms) is a rarely observed life-threatening medical condition due mostly to antipsychotic use. |
2013-12-26 |
2023-08-12 |
Not clear |
| Kumar Muniandy Rajesh, Vellan Sinnathamby, Arul N Sakth. Neuroleptic malignant syndrome masked by cerebral malaria. BMJ case reports. vol 2013. 2013-12-26. PMID:23704432. |
the diagnosis of neuroleptic malignant syndrome (nms) was clinched and the antipsychotics were discontinued. |
2013-12-26 |
2023-08-12 |
Not clear |
| Stephanie Sampson, Mouhamad Mansour, Nicola Maayan, Karla Soares-Weiser, Clive E Adam. Intermittent drug techniques for schizophrenia. The Cochrane database of systematic reviews. issue 7. 2013-12-20. PMID:23881657. |
however, long-term antipsychotic exposure has been associated with a range of adverse effects, including extra-pyramidal symptoms (eps), neuroleptic malignant syndrome (nms), tardive dyskinesia and death. |
2013-12-20 |
2023-08-12 |
Not clear |
| Jennifer L Lyons, Adam B Cohe. Selective cerebellar and basal ganglia injury in neuroleptic malignant syndrome. Journal of neuroimaging : official journal of the American Society of Neuroimaging. vol 23. issue 2. 2013-12-17. PMID:21418121. |
high core body temperatures have been shown to selectively damage the cerebellum and basal ganglia in malignant hyperthermia, but involvement of both areas in neuroleptic malignant syndrome (nms) has not been described. |
2013-12-17 |
2023-08-12 |
Not clear |
| M Punja, A C Pomerleau, J J Devlin, B W Morgan, J G Schier, M D Schwart. Anti-N-methyl-D-aspartate receptor (anti-NMDAR) encephalitis: an etiology worth considering in the differential diagnosis of delirium. Clinical toxicology (Philadelphia, Pa.). vol 51. issue 8. 2013-11-13. PMID:23962100. |
we describe two patients ultimately diagnosed with anti-n-methyl-d-aspartate receptor (nmdar) encephalitis for which a toxicological consultation was requested to evaluate for neuroleptic malignant syndrome (nms). |
2013-11-13 |
2023-08-12 |
Not clear |
| Julie Langan, Daniel Martin, Polash Shajahan, Daniel J Smit. Antipsychotic dose escalation as a trigger for neuroleptic malignant syndrome (NMS): literature review and case series report. BMC psychiatry. vol 12. 2013-10-29. PMID:23194104. |
antipsychotic dose escalation as a trigger for neuroleptic malignant syndrome (nms): literature review and case series report. |
2013-10-29 |
2023-08-12 |
Not clear |